Stay updated on CTX001 in Severe Sickle Cell: Clinical Trial

Sign up to get notified when there's something new on the CTX001 in Severe Sickle Cell: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CTX001 in Severe Sickle Cell: Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The update shows a new Last Update Posted date (2025-08-11) on the study record, with no changes to core content, eligibility criteria, interventions, or primary outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T01:32:33.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    33 days ago
    Change Detected
    Summary
    - Added a system-wide operating status notice and version update (v3.2.0). - Removed a specific resource entry: Hb SS disease (from Genetic and Rare Diseases Information Center).
    Difference
    3%
    Check dated 2025-10-05T13:24:00.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    Update replaces 'Sickle cell anemia' with 'Hb SS disease' and increments the revision from v3.0.2 to v3.1.0.
    Difference
    0.3%
    Check dated 2025-09-28T09:37:51.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.0.2, replacing v3.0.1. The 'Back to Top' element was removed as a minor UI change.
    Difference
    0.2%
    Check dated 2025-09-14T00:11:36.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The web page has been updated to reflect a new version (v3.0.1) and includes a significant addition regarding improvements in health-related quality of life for patients with severe sickle cell disease after a specific treatment.
    Difference
    2%
    Check dated 2025-09-06T20:59:49.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates, including the addition of detailed drug information for Exagamglogene Autotemcel and the inclusion of new research articles related to sickle cell disease. Additionally, the facility name and location have been specified, enhancing the core content of the page.
    Difference
    11%
    Check dated 2025-08-30T15:30:58.000Z thumbnail image

Stay in the know with updates to CTX001 in Severe Sickle Cell: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CTX001 in Severe Sickle Cell: Clinical Trial page.